Finished products that include KSM-66 at a 300-mg dose can use the claims for stress and anxiety, athletic support, and healthy testosterone production.
Ashwagandha products using the KSM-66 ashwagandha brand can now boast a number of functional health claims in the Canadian market. In January, Health Canada issued KSM-66 ashwagandha a Natural Product Number (NPN) and approval three claims, for stress and anxiety, athletic support, and healthy testosterone production.
Finished products that include KSM-66 at a 300-mg dose can use the following claims:
An NPN license indicates that Health Canada has reviewed a product-including clinical study evidence-and deemed it safe, effective, and of high quality.
Because KSM-66’s extract comes from the root of the ashwagandha plant (Withania somnifera), it meets specifications of Health Canada’s own ashwagandha monograph, as well as specifications of the U.S. Pharmacopeia and the British Pharmacopeia.
“Because KSM-66 uses only the root and no other part of the ashwagandha plant, and because Health Canada’s own ashwagandha monograph similarly specifies only the root, these [newly approved health] claims are over and above what is available to formulators who reference the generic Health Canada ashwagandha monograph,” said KSM-66’s supplier Ixoreal Biomed (Hyderabad, India), in a press release.
Also, because the root is what’s most often referenced in clinical ashwagandha studies, “this probably puts KSM-66 on more familiar ground in the minds of governmental regulators across the world,” adds Kartikeya Baldwa, director, Ixoreal.
KSM-66’s NPN is #80047973.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”